A new medical summarization AI agent will help healthcare organizations reduce overall prior authorization turn-around time by up to 50% UiPath will demo Vertex AI integration and showcase platform ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

UiPath Inc. (NYSE: PATH) is one of the worst-performing agentic AI stocks so far in 2026. Based on its January 2, 2026 close of $16.59 and its April 2, 2026 close of $11.24, the stock was down about ...

UiPath PATH is pushing deeper into agentic automation, aiming to move beyond task-level robotic process automation into systems that can reason, plan, and execute across workflows. The strategy is not ...

UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of ...

The latest trends in software development from the Computer Weekly Application Developer Network. UiPath used its annual developer/practitioner event this week in Las Vegas to detail the launch of the ...

UiPath launches AI-based Medical Record Summarization tool, reducing processing time from 45 minutes to minutes. Powered by Google Cloud, the agent improves accuracy, saves 40 minutes per referral, ...

UiPath has seen its revenue growth continually accelerate over the past year. The company has a sticky product, as evidenced by its strong net dollar retention rate. Trading at an inexpensive ...

Software developer UiPath will cut 10% of its workforce, or about 420 jobs, as part of a broader company restructuring. UiPath shares fell 7% on Tuesday and have plunged more than 50% year-to-date. In ...

UiPath, Inc. (NYSE:PATH) ranks among the stocks that could 10x over the next 10 years. On March 16, BMO Capital reduced its price target for UiPath, Inc. (NYSE:PATH) to $14 from $17, retaining a ...

UiPath recently announced a big collaboration with OpenAI to accelerate customers' return on investment by simplifying the development and deployment of AI agents. UiPath's new platform was named one ...